Guías NICE julio 2015

Guías NICE por materias

Guías  NICE por mes - Julio 2015

Reference	Guidance	Programme	Topic
MTG25	The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites	Medical technology guidance	Infections: general and other
QS92	Smoking: harm reduction	Quality standards	Smoking and tobacco
QS93	Atrial fibrillation: treatment and management	Quality standards	Heart rhythm conditions
TA347	Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer	Technology appraisal guidance	Lung cancer
TA346	Aflibercept for treating diabetic macular oedema	Technology appraisal guidance	Macular oedema and retinal vein occlusion
TA348	Everolimus for preventing organ rejection in liver transplantation	Technology appraisal guidance	Liver conditions: general and other
TA350	Secukinumab for treating moderate to severe plaque psoriasis	Technology appraisal guidance	Psoriasis
IPG528	Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean section	Interventional procedure guidance	Intrapartum care
IPG529	Joint distraction for knee osteoarthritis without alignment correction	Interventional procedure guidance	Knee conditions
TA349	Dexamethasone intravitreal implant for treating diabetic macular oedema	Technology appraisal guidance	Macular oedema and retinal vein occlusion
TA351	Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal)	Technology appraisal guidance	Acute coronary syndromes
TA345	Naloxegol for treating opioid‑induced constipation	Technology appraisal guidance	Constipation
QS94	Obesity: prevention and lifestyle weight management in children and young people	Quality standards	Diet, nutrition and obesity
QS96	Dyspepsia and gastro‑oesophageal reflux disease in adults: investigation and management	Quality standards	Digestive tract conditions: general and other
QS95	Bipolar disorder in adults	Quality standards	Bipolar disorder
QSD	In development  Maternal and child nutrition - improving nutritional status	Quality standard	Infants and neonates
MPG	In development  Antimicrobial stewardship	Unclassified	Antibiotic use
QSD	In development  Drug allergy - diagnosis and management	Quality standard	Blood and immune system conditions: general and other
CG	In development  Melanoma	Guidelines	Skin cancer

La importancia del lenguaje en el entorno biosanitario

www.efesalud.com

Para aquellos interesados, y en ocasiones preocupados, por la inadecuada utilización del lenguaje en el ámbito biosantario, la Fundación Dr. Antonio Esteve en colaboración con la Universidad de Salamanca, organizó en mayo de 2014 una mesa redonda con una treintena de expertos en diversas áreas de la divulgación científica. Esta mesa se organizó en cuatro bloques: tres de ellos reflejaron las vertientes principales de la actividad sanitaria profesional: asistencial, investigadora y docente. El cuarto bloque correspondió a la divulgación de la información al conjunto de la sociedad o medios de comunicación.

Todas las ponencias se han recogido en la monografía de la Fundación Dr. Antonio Esteve bajo el título "La importancia del lenguaje en el entorno biosanitario", organizada en  sus cuatro secciones o temáticas:

1. EL LENGUAJE EN EL ÁMBITO ASISTENCIAL
2. EL LENGUAJE EN LA INVESTIGACIÓN BIOMÉDICA
3. EL LENGUAJE EN LA DOCENCIA BIOSANITARIA
4. EL LENGUAJE COMO PUENTE ENTRE LOS PROFESIONALES BIOSANITARIOS Y LA SOCIEDAD

Esta monografía se encuentra en formato papel en la Biblioteca. También se puede descargar en formato pdf gratuitamente con tan sólo registrarse en su página http://www.esteve.org/monografia-lenguaje/.

Fuente: Diario Médico julio 2015

Guías Fisterra junio y julio 2015

  Cabo Fisterra

Guías y novedades Fisterra del mes de junio

Guías Clínicas:

Calendario de vacunaciones por comunidades y ciudades autónomas Esterilización voluntaria Cáncer de testículo ¿Qué son y para qué sirven las GPC? Diseminación e implementación de GPC Biopsia de ganglio centinela

Novedades:

Proceso de reducción de la polifarmacia: una revisión narrativa Influencia del control glucemia en pacientes con Diabetes tipo II sobre la mortalidad (VADT ampliado) Pocas evidencias en el tratamiento de la fatiga en cuidados paliativos (Revisión Cochrane) Guia SIGN sobre manejo de la epilepsia en adultos Tratamiento de la enfermedad vascular periférica: una revisión sistemática Tratamientos de la rosacea: una revisión sistemática               Guías y novedades Fisterra del mes de julio Guías Clínicas: Vacuna meningocócica B Vacuna frente al herpes zóster Conservación y aprovisionamiento de vacunas Rubéola, sarampión y parotiditis Vacuna meningocócica C Vacuna frente a rotavirus Vacunación en el embarazo Vacunas frente al neumococo Vacunación en inmigrantes Varicela Novedades: ¿Qué fármaco elegir para tratar la Hipertensión Arterial? Proceso de reducción de la polifarmacia: una revisión narrativa

Guías NICE, abril, mayo y junio de 2015

Enlace a todas las guías por especialidad

Abril

Reference Guidance Programme Topic STA In development  Systemic lupus erythematosus (autoantibody-positive) - belimumab [ID416] Technology appraisal guidance Systemic lupus erythematosus Mayo Reference Guidance Programme Topic NG9 Bronchiolitis in children Guideline Respiratory infections NG10 Violence and aggression: short-term management in mental health, health and community settings Guideline Patient and service user care NG11 Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges Guideline Patient and service user care

Junio

Reference Guidance Programme Topic NG13 Workplace policy and management practices to improve the health and wellbeing of employees  Guideline Workplaces  NG12 Suspected cancer: recognition and referral  Guideline Cervical cancer  SFCQS88 NICE support for commissioning for personality disorders: borderline and antisocial  Support for commissioning Personality disorders  TA339 Omalizumab for previously treated chronic spontaneous urticaria  Technology appraisal guidance Skin conditions: general and other  TA342 Vedolizumab for treating moderately to severely active ulcerative colitis  Technology appraisal guidance Inflammatory bowel disease  TA341 Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism  Technology appraisal guidance Embolism and thrombosis  TA340 Ustekinumab for treating active psoriatic arthritis (rapid review of technology appraisal guidance 313)  Technology appraisal guidance Arthritis  IPG519 Insertion of an epiretinal prosthesis for retinitis pigmentosa  Interventional procedure guidance Eye conditions: general and other  IPG521 Suture fixation of acute disruption of the distal tibiofibular syndesmosis  Interventional procedure guidance Musculoskeletal conditions: general and other  IPG523 Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosis  Interventional procedure guidance Embolism and thrombosis  NG8 Anaemia management in people with chronic kidney disease  Guideline Blood conditions  DG17 Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index  Diagnostics guidance Prostate cancer  TA343 Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia  Technology appraisal guidance Blood and bone marrow cancers  TA344 Ofatumumab in combination with chlorambucil or bendamustine for untreated chronic lymphocytic leukaemia  Technology appraisal guidance Blood and bone marrow cancers  IPG520 Radiofrequency ablation for gastric antral vascular ectasia  Interventional procedure guidance Upper gastrointestinal bleeding  IPG524 Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism  Interventional procedure guidance Embolism and thrombosis  IPG522 Hysteroscopic morcellation of uterine leiomyomas (fibroids)  Interventional procedure guidance Endometriosis and fibroids  QS90 Urinary tract infections in adults  Quality standards Urinary tract infection  QS91 Prostate cancer  Quality standards Prostate cancer  QS87 Osteoarthritis  Quality standards Arthritis  QS88 Personality disorders: borderline and antisocial  Quality standards Personality disorders  QS89 Pressure ulcers  Quality standards Pressure ulcers  IPG525 Electrotherapy for the treatment of haemorrhoids  Interventional procedure guidance Haemorrhoids and other anal conditions  IPG526 Cyanoacrylate glue occlusion for varicose veins  Interventional procedure guidance Varicose veins  IPG527 Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache  Interventional procedure guidance Headaches  STA In development  Hepatitis C (chronic) - ledipasvir-sofosbuvir [ID742]  Technology appraisal guidance Hepatitis  TA344 Ofatumumab in combination with chlorambucil or bendamustine for untreated chronic lymphocytic leukaemia  Technology appraisal guidance Blood and bone marrow cancers  IPG520 Radiofrequency ablation for gastric antral vascular ectasia  Interventional procedure guidance Upper gastrointestinal bleeding  IPG524 Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism  Interventional procedure guidance Embolism and thrombosis  IPG522 Hysteroscopic morcellation of uterine leiomyomas (fibroids)  Interventional procedure guidance Endometriosis and fibroids  QS90 Urinary tract infections in adults  Quality standards Urinary tract infection  QS91 Prostate cancer  Quality standards Prostate cancer  QS87 Osteoarthritis  Quality standards Arthritis  QS88 Personality disorders: borderline and antisocial  Quality standards Personality disorders  QS89 Pressure ulcers  Quality standards Pressure ulcers  IPG525 Electrotherapy for the treatment of haemorrhoids  Interventional procedure guidance Haemorrhoids and other anal conditions  IPG526 Cyanoacrylate glue occlusion for varicose veins  Interventional procedure guidance Varicose veins  IPG527 Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache  Interventional procedure guidance Headaches  STA In development  Hepatitis C (chronic) - ledipasvir-sofosbuvir [ID742]  Technology appraisal guidance Hepatitis